首页 | 本学科首页   官方微博 | 高级检索  
     

CT 导向下125 I粒子植入联合洛泊碘油化疗乳剂治疗晚期肺癌临床观察
引用本文:李宇鸣. CT 导向下125 I粒子植入联合洛泊碘油化疗乳剂治疗晚期肺癌临床观察[J]. 牡丹江医学院学报, 2014, 0(3): 22-25
作者姓名:李宇鸣
作者单位:阳山县人民医院放射介入科,广东阳山513100
摘    要:目的:观察CT 导向下125 I粒子植入联合经皮穿刺肿瘤内注入洛泊碘油化疗乳剂治疗肺癌临床疗效。方法:9例晚期肺癌患者,在螺旋CT导向下将125 I粒子植入联合经皮穿刺肿瘤内注入洛泊碘油化疗乳剂到肺部肿瘤内。结果:全组9例患者9个病灶,平均治疗后60d采用螺旋CT对肺癌原发灶评价,部分缓解(PR)7例,稳定(NC)1例,进展(PD)1例,总有效率77.8%。结论:CT导向下125 I粒子植入联合经皮穿刺肿瘤内注入洛泊碘油化疗乳剂治疗晚期肺癌安全、创伤小、并发症少,疗效肯定。

关 键 词:晚期肺癌  放射性粒子  洛泊碘油化疗乳剂

CLINICAL EFFICACY OF CT-GUIDED 125 I SEED IMPLANTATION COMBINED WITH INTRATUMORAL INJECTION OF LOBAPLATIN AND LIPIODOL CHEMOTHERAPY EMULSION FOR ADVANCED LUNG CANCER
LI Yuming. CLINICAL EFFICACY OF CT-GUIDED 125 I SEED IMPLANTATION COMBINED WITH INTRATUMORAL INJECTION OF LOBAPLATIN AND LIPIODOL CHEMOTHERAPY EMULSION FOR ADVANCED LUNG CANCER[J]. Journal of Mudanjiang Medical College, 2014, 0(3): 22-25
Authors:LI Yuming
Affiliation:LI Yuming (Department of Radiology, People's Hospital of Yangshan County in Guangdong Province, Yangshan 513100, China)
Abstract:Objective:To investigate the safety and clinical efficacy of CT -guided 125I seed implantation combined with intratu-moral injection of lobaplatin and lipiodol chemotherapy emulsion for advanced lung cancer .Methods Nine patients with advanced lung cancer, 125I seed implantation with CT -guided combined with intratumoral injection of lobaplatin and lipiodol chemotherapy emul -sion.Results All nine lesions in 9 patients, evaluation using spiral CT with an average of 60 days after treatment , partial remission (PR) 7 cases, stable (NC) 1 case, progress (PD) 1 case, the total efficiency of 77.8%.Conclusion CT-guided percutaneous 125 I seed implantation combined with intratumoral injection of lobaplatin and lipiodol chemotherapy emulsion treatment of advanced lung cancer chemotherapy is safe , minimally invasive , fewer complications and more effective .
Keywords:Advanced Lung Cancer  Radioactive Particle  Lobaplatin and Lipiodol Chemotherapy Emulsion
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号